Publications

  1. Heybati K, Ochal D, Hogan W, Al-Khateeb H, Sklar D, Herasevich S, Litzow M, Shah M, Torghabeh MH, Durani U, Bauer P, Gajic O, Yadav H. Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients. Ann Hematol. 2024 Mar; 103 (3):957-967 Epub 2024 Jan 03
    View PubMed
  2. Chohan KL, Bansal R, Hathcock MA, Paludo J, Bennani NN, Johnston PB, Khurana A, Durani U, Wang Y, Ruff MW, Villasboas Bisneto JC, Ansell SM, Lin Y, Kenderian SS. Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience. Leuk Lymphoma. 2024 Mar; 65 (3):389-393 Epub 2023 Nov 30
    View PubMed
  3. Lewis AR, Choong GM, Cathcart-Rake E, Florez N, Durani U, Yadav S, Fuentes H, Sorensen K, Childs DS, Saliba A, Paludo J, Hobday TJ. Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat. J Cancer Educ. 2024 Feb; 39 (1):58-64 Epub 2023 Oct 17
    View PubMed
  4. Porrata LF, Ansell SM, Micallef IN, Johnston PB, Villasboas JC, Paludo J, Durani U, Markovic SN. Day 100 Natural Killer Cell/CD14+HLA-DR(DIM) ratio and survival in lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation. Clin Transplant. 2024 Jan; 38 (1):e15211 Epub 2023 Dec 01
    View PubMed
  5. Desai A, Xiao A, Smith C, Jensen C, Pritchett J, Soefje S, Durani U, Go R, Scheckel C, Hematology Oncology Outcomes Research Group. Analysis of Medicare Expenditure for Discarded Infused Cancer Therapeutics From 2017-2020. Mayo Clin Proc. 2023 Dec; 98 (12):1767-1773
    View PubMed
  6. Lee MK, Durani U, Zhang N, Hilal T, Warsame RM, Borah B, Khera N, Griffin JM. Relationships Among Health Insurance Literacy, Financial Toxicity, and Sociodemographic Factors in Patients With Cancer. JCO Oncol Pract. 2023 Oct; 19 (10):888-898 Epub 2023 Aug 24
    View PubMed
  7. Wiedmeier-Nutor JE, Iqbal M, Rosenthal AC, Bezerra ED, Garcia-Robledo JE, Bansal R, Johnston PB, Hathcock M, Larsen JT, Bergsagel PL, Wang Y, Reeder CB, Leis JF, Fonseca R, Palmer JM, Gysbers BJ, Mwangi R, Warsame RM, Kourelis T, Hayman SR, Dingli D, Kapoor P, Kumar SK, Durani U, Villasboas JC, Paludo J, Bennani NN, Nowakowski G, Ansell SM, Castro JE, Kharfan-Dabaja MA, Lin Y, Vergidis P, Murthy HS, Munoz J. Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2023 Jun; 23 (6):456-462 Epub 2023 Mar 07
    View PubMed
  8. Banerjee R, Kelkar AH, Durani U, Anagnostou T, Nishitani M, Mallhi K, Majhail NS, Logan AC. Demographics, Motivations, and Experiences of Participants in Transplantation or Cellular Therapy Fellowships. Transplant Cell Ther. 2023 Jun; 29 (6):394.e1-394.e7 Epub 2023 Mar 17
    View PubMed
  9. Singhal S, Saadeh SS, Durani U, Kansagra A, Alkhateeb HB, Shah MV, Mangaonkar A, Kenderian S, Hashmi S, Patnaik MV, Litzow MR, Hogan WJ. Allogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic Experience. Transplant Cell Ther. 2023 Mar; 29 (3):183.e1-183.e6 Epub 2022 Dec 28
    View PubMed
  10. Acosta-Medina AA, Johnson IM, Bansal R, Hathcock M, Kenderian SJ, Durani U, Khurana A, Wang Y, Paludo J, Villasboas JC, Bennani NN, Johnston PB, Ansell SM, Lin Y, Alkhateeb HB. Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma. Blood Cancer J 2023 Jan 5; 13 (1):7 Epub 2023 Jan 05
    View PubMed
  11. Storandt MH, Durani U, Stan D, Larson N, Loprinzi C, Couch F, Olson JE, Khera N, Ruddy KJ. Financial hardship in breast cancer survivors: a prospective analysis of change in financial concerns over time. Support Care Cancer. 2022 Dec 19; 31 (1):62
    View PubMed
  12. Hatic H, Inselman S, Inselman J, Kommalapati A, Tella SH, Paludo J, Durani U, Go RS, Goyal G. Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM). Leuk Res. 2022 Dec; 123:106966 Epub 2022 Oct 13
    View PubMed
  13. Alabdaljabar MS, Durani U, Thompson CA, Constine LS, Hashmi SK. The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship. Am J Hematol. 2022 Dec; 97(12):1627-1637. Epub 2022 Oct 01.
    View PubMed
  14. Sidana S, Dueck AC, Thanarajasingam G, Griffin JM, Thompson C, Griffin JM, Thompson C, Durani U, Burtis M, Warsame R, Paludo J, Gertz MA, Dispenzieri A, Ansell SM, Rajkumar SV, Yost K, Bennani N, Lin Y, Kumar S. Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant. Transplant Cell Ther. 2022 Aug; 28 (8):473-482 Epub 2022 May 09
    View PubMed
  15. Major A, Cliff ERS, Ermann DA, Durani U, Russler-Germain DA. Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions. EJHaem. 2022 Aug; 3 (3):930-935 Epub 2022 June 16
    View PubMed
  16. Khera N, Zhang N, Hilal T, Durani U, Lee M, Padman R, Voleti S, Warsame RM, Borah BJ, Yabroff KR, Griffin JM. Association of Health Insurance Literacy With Financial Hardship in Patients With Cancer. JAMA Netw Open. 2022 Jul 1; 5 (7):e2223141 Epub 2022 July 01
    View PubMed
  17. Durani U, Major A, Velazquez AI, May J, Nelson M, Zheng Z, Hall AG, Alam ST, Reynolds R, Thompson JC, Kumbamu A, Das DG, Murphy MC, Henry E, Lee AI, Marshall AL, Wun T, Weeks LD. Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment. JCO Oncol Pract. 2022 Apr; 18 (4):e586-e599 Epub 2022 Jan 06
    View PubMed
  18. Velazquez AI, Durani U, Weeks LD, Major A, Reynolds R, Kumbamu A, Das DG, Murphy MC, Henry E, Lee AI, Marshall AL. Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors. JCO Oncol Pract. 2022 Apr; 18 (4):e551-e563 Epub 2022 Jan 11
    View PubMed
  19. Durani U. Stem cell Transplant in Hodgkin Lymphoma: An Evolving Field. Transplant Cell Ther 2022 Mar; 28 (3):123-124
    View PubMed
  20. Durani U, Ansell SM. CD5+ diffuse large B-cell lymphoma: a narrative review. Leuk Lymphoma. 2021 Dec; 62 (13):3078-3086 Epub 2021 July 21
    View PubMed
  21. Shultz AM, Squires RW, Shin JY, Durani U, Pophali PA. Cardio-Oncology Rehabilitation (CORE) Exercise Prescription and Programming: A PRACTICAL GUIDE. J Cardiopulm Rehabil Prev. 2021 Sep 1; 41 (5):341-344
    View PubMed
  22. Patel SR, St Pierre F, Velazquez AI, Ananth S, Durani U, Anampa-Guzmán A, Castillo K, Dhawan N, Oxentenko AS, Duma N. The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards. Oncologist. 2021 Sep; 26(9):779-786. Epub 2021 Jul 09.
    View PubMed
  23. Martin MJ, Pennington KM, Skalski JH, Yi ES, Levin DL, Durani U, Ryu JH. Emphysematous Lung Lesions Caused by Perivascular and Alveolar-Septal Deposition of Amyloid Light-Chain Amyloidosis. Chest. 2021 Aug; 160(2):e169-e171.
    View PubMed
  24. Pophali PA, Durani U, Shin J, Larson MC, Shultz A, Becker J, Bowman M, Thompson C, Cathcart-Rake EJ. A pilot study of individualized exercise prescription to improve physical activity in cancer survivors. Journal of Clinical Oncology. 2021; 39(15).
  25. Durani U, Asante D, Heien HC, Thompson CA, Halfdanarson T, Sangaralingham L, Peethambaram P, Quevedo FJ, Villasboas JC, Go RS. Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely Recommendations. JCO Oncol Pract. 2021 Apr; 17(4):e490-e496. Epub 2020 Oct 23.
    View PubMed
  26. Riaz IB, Siddiqi R, Zahid U, Durani U, Fatima K, Sipra QR, Raina AI, Farooq MZ, Chamberlain AM, Wang Z, Go RS, Marshall AL, Khosa F. Gender Differences in Faculty Rank and Leadership Positions Among Hematologists and Oncologists in the United States. JCO Oncol Pract. 2020 Jun; 16 (6):e507-e516 Epub 2020 Feb 06
    View PubMed
  27. Duma N, Idossa DW, Durani U, Frank RD, Paludo J, Westin G, Lou Y, Mansfield AS, Adjei AA, Go RS, Ailawadhi S. Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2020 May; 21 (3):e115-e129 Epub 2019 Aug 30
    View PubMed
  28. Durani U, Hogan WJ. Emergencies in haematology: tumour lysis syndrome. Br J Haematol. 2020 Feb; 188 (4):494-500 Epub 2019 Nov 27
    View PubMed
  29. Yadav S, Karam D, Bin Riaz I, Xie H, Durani U, Duma N, Giridhar KV, Hieken TJ, Boughey JC, Mutter RW, Hawse JR, Jimenez RE, Couch FJ, Leon-Ferre RA, Ruddy KJ. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer. 2020 Jan 1; 126 (1):26-36 Epub 2019 Oct 07
    View PubMed
  30. Duma N, Durani U, Woods CB, Kankeu Fonkoua LA, Cook JM, Wee C, Fuentes HE, Gonzalez-Velez M, Murphy MC, Jain S, Marshall AL, Graff SL, Knoll MA. Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference. J Clin Oncol. 2019 Dec 20; 37 (36):3538-3545 Epub 2019 Oct 11
    View PubMed
  31. Daniels LM, Durani U, Barreto JN, O'Horo JC, Siddiqui MA, Park JG, Tosh PK. Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia. Support Care Cancer. 2019 Nov; 27 (11):4171-4177 Epub 2019 Feb 25
    View PubMed
  32. Durani U, Asante D, Halfdanarson T, Heien HC, Sangaralingham L, Thompson CA, Peethambaram P, Quevedo FJ, Go RS. Use of Imaging During Staging and Surveillance of Localized Colon Cancer in a Large Insured Population. J Natl Compr Canc Netw. 2019 Nov 1; 17 (11):1355-1361
    View PubMed
  33. Yadav S, Xie H, Bin-Riaz I, Sharma P, Bin-Riaz I, Durani U, Goyal G, Borah B, Borad MJ, Smoot RL, Roberts LR, Go RS, McWilliams RR, Mahipal A. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis. Eur J Surg Oncol. 2019 Aug; 45 (8):1432-1438 Epub 2019 Mar 21
    View PubMed
  34. Durani U, Go RS. In Reply. Oncologist 2018 Dec; 23 (12):e163 Epub 2018 July 16
    View PubMed
  35. Durani U, Go RS, Kay NE. Immune-mediated hemolytic anemia and thrombocytopenia in clonal B-cell disorders: a review. Clin Adv Hematol Oncol. 2018 Oct; 16 (10):670-676
    View PubMed
  36. Goyal G, Bartley AC, Funni S, Inselman J, Shah ND, Marshall AL, Ashrani AA, Kapoor P, Durani U, Hashmi SK, Siddiqui MA, Buadi FK, Go RS, Kyle RA, Kumar S, Gonsalves WI. Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset. Leukemia. 2018 Jun; 32 (6):1414-1420 Epub 2018 Mar 21
    View PubMed
  37. Durani U, Gallo de Moraes A, Beachey J, Nelson D, Robinson S, Robinson S, Anavekar NS. Epithelioid angiosarcoma: A rare cause of pericarditis and pleural effusion. Respir Med Case Rep. 2018; 24:77-80 Epub 2018 Apr 20
    View PubMed
  38. Durani U, Shah ND, Go RS. In-Hospital Outcomes of Tumor Lysis Syndrome: A Population-Based Study Using the National Inpatient Sample. Oncologist. 2017 Dec; 22 (12):1506-1509 Epub 2017 Sept 13
    View PubMed
  39. Marshall AL, Durani U, Bartley A, Hagen CE, Ashrani A, Rose C, Go RS, Pruthi RK. The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample-based analysis. Am J Obstet Gynecol. 2017 Sep; 217 (3):344.e1-344.e6 Epub 2017 May 11
    View PubMed
  40. Durani U, Go RS. Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States. Am J Hematol 2017 Jun; 92 (6):E99-E101 Epub 2017 Apr 29
    View PubMed
  41. Durani U, Go RS. Racial and ethnic disparities in the survival of adolescents and young adults with acute myeloid leukemia: a retrospective study using the US National Cancer Data Base. Leuk Lymphoma. 2017 May; 58 (5):1184-1189 Epub 2016 Nov 03
    View PubMed
  42. Marshall AL, Bartley AC, Ashrani AA, Pruthi RK, Durani U, Gonsalves WI, Kapoor P, Hashmi SK, Siddiqui MA, Go RS. Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis. Vasc Med. 2017 Apr; 22 (2):121-127 Epub 2017 Mar 20
    View PubMed
  43. Durani U, Dioverti Prono MV, Tosh PK, Patnaik M, Barreto JN, Tande AJ. Influenza infection in neutropenic adults. Infect Dis (Lond). 2017 Feb; 49 (2):141-146 Epub 2016 Sept 16
    View PubMed
  44. Durani U, Tosh PK, Barreto JN, Estes LL, Jannetto PJ, Tande AJ. Retrospective Comparison of Posaconazole Levels in Patients Taking the Delayed-Release Tablet versus the Oral Suspension. Antimicrob Agents Chemother. 2015 Aug; 59 (8):4914-8 Epub 2015 June 08
    View PubMed